BRIEF published on 06/17/2026 at 09:05, 10 days 3 hours ago Aiforia Technologies Secures Potential €20M EIB Venture Debt European Investment Bank Non-binding Agreement Aiforia Technologies Venture Debt Funding Outlook
PRESS RELEASE published on 06/17/2026 at 09:00, 10 days 3 hours ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj agrees on a non-binding indicative term sheet with the European Investment Bank (EIB) for a venture debt facility of up to € 20m, de-risking funding outlook and boosting investor confidence Investor Confidence European Investment Bank Aiforia Technologies Oyj Funding Outlook Venture Debt Facility
BRIEF published on 05/11/2026 at 09:05, 1 month 16 days ago NuWays AG Recommends Buy for Aiforia Technologies Oyj NuWays AG Oncology Diagnostics Aiforia Technologies AI Pathology Healthcare M&A
PRESS RELEASE published on 05/11/2026 at 09:00, 1 month 16 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Update on Aiforia Technologies Oyj classification from NuWays AG including strong market catalyst and analysis on AI pathology in the clinical oncology diagnostics field NuWays AG Market Analysis Oncology Diagnostics Aiforia Technologies Oyj AI Pathology
BRIEF published on 04/17/2026 at 09:05, 2 months 10 days ago Aiforia Technologies Secures Exclusive AI Partnership in France AI Diagnostics Aiforia Technologies PROSTIA Project AP-HP Partnership French Healthcare
PRESS RELEASE published on 04/17/2026 at 09:00, 2 months 10 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj selected as sole AI partner for PROSTIA project by Assistance Publique-Hôpitaux de Paris, expanding cancer diagnostics in France. Landmark deployment validates Aiforia's market leadership Cancer Diagnostics France AI Partner Aiforia Technologies Oyj PROSTIA Project
BRIEF published on 03/11/2026 at 09:05, 3 months 16 days ago Aiforia Technologies Oyj Sees Clinical Growth Surge European Market Cash Position Profitability Improvement Client Expansion Clinical Growth
PRESS RELEASE published on 03/11/2026 at 09:00, 3 months 16 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj by NuWays AG analyzed: Clinical growth accelerates, profitability improves with increased share of wallet and workforce reductions. Target price EUR 3.8 Profitability NuWays AG Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 03/09/2026 at 09:05, 3 months 18 days ago Aiforia Technologies Oyj Poised for Growth in Clinical Segment Strategic Partnerships Revenue Expansion EBITDA Improvement Market Share Clinical Growth
PRESS RELEASE published on 03/09/2026 at 09:00, 3 months 18 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's clinical segment shows strong growth with a clear roadmap for scaling, leading to improved profitability and strategic partnerships. Research recommends buying with a target price of EUR 3.80 Strategic Partnerships Profitability Target Price Aiforia Technologies Oyj Clinical Growth
Published on 06/27/2026 at 01:40, 10 hours 55 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 12 hours 35 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 13 hours 35 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 13 hours 45 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 14 hours 20 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 12 hours 30 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 12 hours 31 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 12 hours 59 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 12 hours 59 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 13 hours 8 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 07:00, 1 day 5 hours ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 07:30, 2 days 5 hours ago Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.
